Evidence map›Paper›PMID 37400552›Full record

ArticleNature2023

Author Correction: Clonal haematopoiesis and risk of chronic liver disease.

Waihay J Wong, Connor Emdin, Alexander G Bick, Seyedeh M Zekavat, Abhishek Niroula, James P Pirruccello, Laura Dichtel, Gabriel Griffin, Md Mesbah Uddin, Christopher J Gibson and 27 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Waihay J Wong *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2023-6590
Connor Emdin *Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Alexander G BickBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Seyedeh M ZekavatBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4026-8944
Abhishek NiroulaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James P PirruccelloBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6088-4037
Laura DichtelNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Gabriel GriffinDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Md Mesbah UddinBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1846-0411
Christopher J GibsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3700-5310
Veronica KovalcikDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amy E LinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Marie E McConkeyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amelie VrommanDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1724-2095
Rob S SellarDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Peter G KimDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8716-8759
Mridul AgrawalDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Joshua WeinstockDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-7013-1899
Michelle T LongSection of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6131-3981
Bing YuDepartment of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
Rajarshi BanerjeePerspectum Ltd, Oxford, UK.
Rowan C NichollsPerspectum Ltd, Oxford, UK.ORCID http://orcid.org/0000-0002-3311-4974
Andrea DennisPerspectum Ltd, Oxford, UK.
Matt KellyPerspectum Ltd, Oxford, UK.ORCID http://orcid.org/0000-0002-5834-635X
Po-Ru LohBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5542-9064
Steve McCarrollBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6954-8184
Eric BoerwinkleHuman Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Ramachandran S VasanThe University of Texas School of Public Health San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0001-7357-5970
Siddhartha JaiswalDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9597-0477
Andrew D JohnsonPopulation Sciences Branch, National Heart, Lung, and Blood Institute, Framingham, MA, USA.ORCID http://orcid.org/0000-0001-6369-5178
Raymond T ChungDepartment of Medicine, Harvard Medical School, Boston, MA, USA.
Kathleen CoreyDepartment of Medicine, Harvard Medical School, Boston, MA, USA.
Daniel LevyFramingham Heart Study of the NHLBI and Boston University School of Medicine, Framingham, MA, USA.ORCID http://orcid.org/0000-0003-1843-8724
Christie BallantyneDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6432-1730
NHLBI TOPMed Hematology Working Group
Benjamin L EbertDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Benjamin_Ebert@dfci.harvard.edu.ORCID http://orcid.org/0000-0003-0197-5451
Pradeep NatarajanBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. pnatarajan@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-8402-7435

Funding

Framingham Project/LevyZIAHL006001 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEVY, DANIEL · 2009 to 2025
$51.1M
Center for Hemoglobin Research in Minorities (CHaRM)P50HL118006 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2013 to 2017
$7.0M
DNA methylation markers of Multimorbidity in Aging Humans and MiceK01AG059898 · NIA · UNIVERSITY OF WASHINGTON · PI SALIMI, SHABNAM · 2019 to 2023
$613k
NHLBI NIH HHS P50 HL118006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.